Pentixapharm Holding AG (ETR:PTP) | Finanzwire

Basculer en Français

9811	Companies
196812	Keywords
127831	Articles
104640	Press releases

Headlines Articles Press releases Pentixapharm Holding AG

Home
Companies
Pentixapharm Holding AG

BRIEF

published on 11/04/2024 at 17:31, 1 year 3 months ago

Pentixapharm Applauds CMS Reimbursement Enhancement for Radiopharmaceuticals

Radiopharmaceuticals Pentixapharm CMS Decision Reimbursement Policy Diagnostic Innovation
PRESS RELEASE

published on 11/04/2024 at 17:26, 1 year 3 months ago

Pentixapharm Welcomes CMS Decision to Enhance Reimbursement for Diagnostic Radiopharmaceuticals
Pentixapharm welcomes CMS decision to enhance reimbursement for diagnostic radiopharmaceuticals, which could impact future streams for Ga68-PentixaFor and have broader market implications

Radiopharmaceuticals Reimbursement Pentixapharm Ga68-PentixaFor CMS Decision
BRIEF

published on 10/29/2024 at 11:51, 1 year 3 months ago

Pentixapharm's PentixaFor Enters Advanced US Clinical Trials

Clinical Trial Pentixapharm PentixaFor Adrenal Tumors PET Scans
PRESS RELEASE

published on 10/29/2024 at 11:46, 1 year 3 months ago

Pentixapharm Holding AG: US National Cancer Institute Starts Advanced Clinical Trial with PentixaFor
US National Cancer Institute initiates clinical trial with PentixaFor, a new radioactive tracer, to aid in identifying adrenal tumors through PET scans, potentially benefiting patients with aldosteronism and Cushing's syndrome

Clinical Trial PentixaFor Adrenal Tumors PET Scans NIH
BRIEF

published on 10/28/2024 at 12:31, 1 year 3 months ago

Nuclear Medicine Expert Ken Herrmann Joins Pentixapharm's Board

Supervisory Board Nuclear Medicine Radiopharmaceuticals Oncology Pipeline Ken Herrmann
PRESS RELEASE

published on 10/28/2024 at 12:26, 1 year 3 months ago

Nuclear Medicine Specialist Ken Herrmann Joins Supervisory Board of Pentixapharm Holding AG
Nuclear Medicine Specialist Ken Herrmann joins Pentixapharm Holding AG's Supervisory Board, bringing expertise in radiopharmaceuticals and theranostics. His appointment aims to advance oncology pipeline

Oncology Nuclear Medicine Radiopharmaceuticals Pentixapharm Ken Herrmann
BRIEF

published on 10/25/2024 at 16:05, 1 year 3 months ago

Pentixapharm Holding AG Announces Leadership Changes

Leadership Changes Supervisory Board Pentixapharm Dr. Hakim Bouterfa Dr. Dirk Pleimes
PRESS RELEASE

published on 10/25/2024 at 16:00, 1 year 3 months ago

Pentixapharm Holding AG: Upcoming Changes in the Management and Supervisory Boards of the Pentixapharm Group
Pentixapharm Holding AG announces upcoming changes in management and supervisory boards, including CEO transition and new board appointments

CEO Transition Supervisory Board Management Changes Pentixapharm Holding AG Nuclear Medicine Specialist
BRIEF

published on 10/19/2024 at 12:33, 1 year 3 months ago

Pentixapharm's CXCR4 Compound Showcased at EANM Conference

Radiopharmaceuticals Pentixapharm CXCR4 Targeting EANM Conference Theranostic Development
PRESS RELEASE

published on 10/19/2024 at 12:28, 1 year 3 months ago

Pentixapharm’s CXCR4 Core Compound Subject of 17 Abstract Presentations at the Hamburg European Association of Nuclear Medicine (EANM)
Pentixapharm presents CXCR4 targeting compounds in 17 abstracts at EANM Congress, showcasing theranostic developments and research initiatives in various medical areas

Radiopharmaceuticals Pentixapharm Theranostic Development CXCR4 EANM Congress

Accesswire

Published on 02/05/2026 at 15:10, 15 minutes ago

Electric Metals (USA) Limited Announces Change of Auditor
Published on 02/05/2026 at 14:50, 35 minutes ago

High Tide Resources Announces Non-Brokered Private Placements
Published on 02/05/2026 at 14:30, 55 minutes ago

Electrovaya Announces Date for Q1-2026 Financial Results & Conference Call
Published on 02/05/2026 at 14:30, 55 minutes ago

Innodata to Report Fourth Quarter and Fiscal Year 2025 Results
Published on 02/05/2026 at 14:00, 1 hour 25 minutes ago

Organto Foods Inc. Expects Strong 2026 Growth Driven by Retail Wins and Expanded Supply Partnerships

View all ACCESSWIRE

EQS Group

Published on 02/05/2026 at 15:15, 10 minutes ago

FIS SUCCESSFULLY COMPLETES €770 MILLION BOND ISSUANCE
Published on 02/05/2026 at 15:13, 12 minutes ago

Form 8.3 - The Vanguard Group, Inc.: JTC plc
Published on 02/05/2026 at 15:12, 12 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Glencore plc
Published on 02/05/2026 at 15:12, 13 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc
Published on 02/05/2026 at 15:11, 14 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Beazley plc

Les Echos

Published on 02/05/2026 at 11:30, 3 hours 55 minutes ago

Disclosure of shares outstanding and voting rights - 05.02.2026
Published on 02/04/2026 at 18:04, 21 hours 21 minutes ago

Total number of voting rights and shares making up the share capital at January 31, 2026
Published on 02/04/2026 at 17:45, 21 hours 40 minutes ago

Information concerning the total number of voting rights and shares 2026 01 31
Published on 02/04/2026 at 17:45, 21 hours 40 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 02/04/2026 at 17:45, 21 hours 40 minutes ago

January 2026

View all LES ECHOS COMFI WIRE